Seeking Alpha

J&J posts mid-stage trial win for oral ulcerative colitis therapy

Johnson & Johnson (NYSE:JNJ) said on Monday that its mid-stage study of icotrokinra, for the treatment of moderate to severe active ulcerative colitis, met the main goal. JNJ stock up about 1% in ...
Benzinga.com

Palatin Technologies Touts Positive Results From Mid-Stage Study For Experimental Drug For Ulcerative Colitis, Halts Patients Enrollment Citing Strategic Focus

Palatin Technologies Inc. (NYSE:PTN) on Friday released topline results from its Phase 2 study of PL8177, a selective melanocortin-1 receptor (MC1R) agonist, in patients with active ulcerative colitis ...

Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn’s disease, and ...
Hosted on MSN

Abivax soars 400% after ulcerative colitis drug hits targets in late-stage trials

Shares of Abivax (NASDAQ:ABVX) surged more than 400% in Paris trading on Wednesday after the French biotech company announced that its experimental drug obefazimod met key goals in two pivotal Phase 3 ...
FOX31 Denver

Microbiotica unveils data on the mechanism of action of MB310, a clinical-stage drug candidate in development for the treatment of ulcerative colitis

CAMBRIDGE, United Kingdom, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic ...
Reuters

Salix says late-stage trial for ulcerative colitis drug positive

Oct 4 (Reuters) - Salix Pharmaceuticals Ltd said a second late-stage trial of its new granulated mesalamine product to treat ulcerative colitis showed positive results. The specialty pharmaceutical ...